JIM
MYGN icon

Jupiter Investment Management’s Myriad Genetics MYGN Stock Holding History

Jupiter Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15,346
Closed -$573K – 421
2018
Q2 		$573K Sell
15,346
-35,523
-70% -$1.2M ﹤0.01% 315
2018
Q1 		$1.5M Buy
+50,869
New +$1.72M 0.01% 252
2016
Q4 		– Sell
-299,783
Closed -$6.17M – 417
2016
Q3 		$6.17M Sell
299,783
-42,723
-12% -$1.08M 0.11% 142
2016
Q2 		$10.5M Buy
342,506
+32,561
+11% +$1.13M 0.2% 124
2016
Q1 		$11.6M Buy
309,945
+281,587
+993% +$10.6M 0.24% 120
2015
Q4 		$1.22M Sell
28,358
-2,190
-7% -$92.5K 0.03% 174
2015
Q3 		$1.14M Sell
30,548
-48,373
-61% -$1.72M 0.03% 183
2015
Q2 		$2.68M Sell
78,921
-82,728
-51% -$2.81M 0.08% 128
2015
Q1 		$5.72M Buy
161,649
+6,975
+5% +$250K 0.18% 105
2014
Q4 		$5.27M Buy
154,674
+125,593
+432% +$4.46M 0.19% 125
2014
Q3 		$1.12M Buy
29,081
+4,503
+18% +$168K 0.06% 221
2014
Q2 		$956K Sell
24,578
-51,967
-68% -$1.93M 0.05% 233
2014
Q1 		$2.62M Sell
76,545
-359,982
-82% -$11.2M 0.18% 151
2013
Q4 		$9.16M Buy
436,527
+60,355
+16% +$1.53M 0.77% 40
2013
Q3 		$8.84M Buy
376,172
+313,136
+497% +$8.9M 0.84% 32
2013
Q2 		$1.69M Buy
+63,036
New +$1.83M 0.2% 168

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jupiter Investment Management's MYGN Position: Q3 2018 in Review

Jupiter Investment Management sold out of Myriad Genetics (MYGN) in Q3 2018, closing a stake of 15,346 shares — an estimated $573K sold.

Jupiter Investment Management first reported a position in MYGN in Q2 2013 and held it in 16 quarters. The position peaked at $11.6M in Q1 2016. 284 funds tracked by Wall St. Rank hold MYGN as of Q3 2018.

  • Jupiter Investment Management reported no remaining Myriad Genetics position as of Q3 2018 after selling out during the quarter.
  • Jupiter Investment Management sold 15,346 Myriad Genetics shares in Q3 2018, an estimated $573K.
  • Jupiter Investment Management first reported a position in Myriad Genetics in Q2 2013 and held it in 16 quarters.
  • Jupiter Investment Management's Myriad Genetics position peaked at $11.6M in Q1 2016.
  • 284 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2018.

Based on Jupiter Investment Management's 13F filing for Q3 2018, filed 17 Oct 2018.